ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
March 3, 2021
Couple with doctor
March 3, 2021
Categories
  • Editorials

COVID-19 and clinical trials: Continuing care in a pandemic

Cancer does not stop for COVID, and neither should cancer screening or treatment
Do you like it?
0 Read more
March 3, 2021
Man holding throat
March 3, 2021
Categories
  • New Trials

Now Enrolling: Clinical trial EA2174 is evaluating a new treatment approach for patients with esophagus cancer

This trial is testing if the addition of immunotherapy to the usual treatment will lead to better results for patients with esophagus or gastroesophagus cancer
Do you like it?
0 Read more
March 3, 2021
Research dictionary entry
March 3, 2021
Categories
  • Trial Results

Trial Results: Recent ECOG-ACRIN research

Over the last several months, ECOG-ACRIN researchers have published the results of at least seven clinical trials
Do you like it?
0 Read more
Prev page
1234

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Tags

Acute lymphoblastic leukemia Adolescents and young adults Advocacy Bladder cancer Breast cancer Caregiving Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy In memory Kidney cancer Leukemia Lung cancer Lymphoma Mammography Mantle cell lymphoma Melanoma Multiple myeloma Myeloma NCI-MATCH Nose and sinus cancer Pancreatic cancer Pancreatic cysts Patient care Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Renal cell carcinoma Research results Sarcoma Screening Side effects Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc